UNSPSC 51181925: Zuclomifene or zuclomiphene

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51181925

Definition

This classification denotes an antiestrogen with the molecular formula C26H28ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3JU1DU3652, chemically known as 2-(p-(2-chloro-1,2-diphenylvinyl)phenoxy)triethylamine but generally known as zuclomifene, which bears US NIH Compound Identifier 1548955. European Medicines Agency schedules Zuclomifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00194MIG.

Read the full definition

The term ZUCLOMIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). ZUCLOMIFENE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Zuclomifene or zuclomiphene bears US NLM identifiers UMLS ID C0087182 and NCI Concept Code C66870. SMILES: CL/C(=C(\C1CCC(OCCN(CC)CC)CC1)C1CCCCC1)C1CCCCC1.

About UNSPSC 51181925

UNSPSC 51181925 Zuclomifene or zuclomiphene is a Commodity code covering active pharmaceutical ingredients and finished products used in state and local government healthcare, pharmaceutical procurement, and pharmacy operations. Recent state and local solicitations under this code show activity in multi-source generic pharmaceutical supply agreements where zuclomifene and similar therapeutics are sourced through authorized wholesale distribution networks to support government healthcare facilities. The work involves pharmaceutical manufacturers submitting detailed product specifications, pricing, compliance documentation, and supply-chain commitments to qualify for inclusion in cooperative purchasing contracts serving multiple jurisdictions and institutional buyers.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued a Request for Proposal in January 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, covering participating state and local government facilities across Minnesota, Oregon, and other member states. Vendors must maintain relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), comply with cGMP and DSCSA requirements, carry $5 million commercial general liability insurance, and submit detailed NDC codes, SKUs, and pricing in Excel/CSV format through the ePro system. The contract term runs two years for new responders with optional extensions, effective July 1, 2026, with price competitiveness weighted at 75 percent of the evaluation and all products required in the marketplace by May 15, 2026.

Quick answers

What is UNSPSC 51181925?

UNSPSC 51181925 is Zuclomifene or zuclomiphene, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51181925?

UNSPSC 51181925 maps to 1 NIGP code, 26968 Hormones and Synthetic Substitutes.

On GovTribe

See everything under UNSPSC 51181925

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code